chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Diarrhoea, Dizziness, Headache
Clinical narrative: diarrhea; really sick; dizziness; chills; Headache; nausea; fever on and off; joint pain; vomiting; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 26-Feb-2021 and was forwarded to Moderna on 28-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea), ILLNESS (really sick), DIZZINESS (dizziness), CHILLS (chills) and HEADACHE (Headache) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 22-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Feb-2021, the patient experienced DIARRHOEA (diarrhea), ILLNESS (really sick), DIZZINESS (dizziness), CHILLS (chills), HEADACHE (Headache), NAUSEA (nausea), PYREXIA (fever on and off), ARTHRALGIA (joint pain) and VOMITING (vomiting). The patient was treated with PARACETAMOL (TYLENOL) for Headache, at a dose of 1 dosage form. At the time of the report, DIARRHOEA (diarrhea), ILLNESS (really sick), DIZZINESS (dizziness), CHILLS (chills), HEADACHE (Headache), NAUSEA (nausea), PYREXIA (fever on and off), ARTHRALGIA (joint pain) and VOMITING (vomiting) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided. She is not taking other medications.Concomitant product use was not provided.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Illness, Nausea, Pyrexia, Vomiting
Clinical narrative: diarrhea; really sick; dizziness; chills; Headache; nausea; fever on and off; joint pain; vomiting; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 26-Feb-2021 and was forwarded to Moderna on 28-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea), ILLNESS (really sick), DIZZINESS (dizziness), CHILLS (chills) and HEADACHE (Headache) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 22-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Feb-2021, the patient experienced DIARRHOEA (diarrhea), ILLNESS (really sick), DIZZINESS (dizziness), CHILLS (chills), HEADACHE (Headache), NAUSEA (nausea), PYREXIA (fever on and off), ARTHRALGIA (joint pain) and VOMITING (vomiting). The patient was treated with PARACETAMOL (TYLENOL) for Headache, at a dose of 1 dosage form. At the time of the report, DIARRHOEA (diarrhea), ILLNESS (really sick), DIZZINESS (dizziness), CHILLS (chills), HEADACHE (Headache), NAUSEA (nausea), PYREXIA (fever on and off), ARTHRALGIA (joint pain) and VOMITING (vomiting) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided. She is not taking other medications.Concomitant product use was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Maternal exposure during pregnancy
Clinical narrative: Vaccine exposure during pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On 20-Feb-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy). On 20-Feb-2021, MATERNAL EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication were reported No treatment medication were reported.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Headache, Migraine, Myalgia, Pain
Clinical narrative: allergic rhinitis; extreme migraine; fever 100.2F; body aches all over/slight soreness in the arm occasionally after the shot for a week or two; headache -25 Feb 2021; aches and pains; This case was initially received via an unknown source (no reference has been entered for a health authority or license partner) on 27-Feb-2021. The most recent information was received on 26-May-2021 and was forwarded to Moderna on 26-May-2021.    This spontaneous case was reported by a consumer and describes the occurrence of RHINITIS ALLERGIC (allergic rhinitis), MIGRAINE (extreme migraine), PAIN (aches and pains), PYREXIA (fever 100.2F) and MYALGIA (body aches all over/slight soreness in the arm occasionally after the shot for a week or two) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Previously administered products included for an unreported indication: SHINGRIX.   On 25-Feb-2021 at 1:00 PM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2021, the patient experienced PAIN (aches and pains) and HEADACHE (headache -25 Feb 2021). On 26-Feb-2021, the patient experienced MIGRAINE (extreme migraine), PYREXIA (fever 100.2F) and MYALGIA (body aches all over/slight soreness in the arm occasionally after the shot for a week or two). On an unknown date, the patient experienced RHINITIS ALLERGIC (allergic rhinitis). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at an unspecified dose and frequency; ACETYLSALICYLIC ACID (BAYER ASPIRIN) at an unspecified dose and frequency and ACETYLSALICYLIC ACID, CAFFEINE, PARACETAMOL (EXCEDRIN MIGRAINE) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, RHINITIS ALLERGIC (allergic rhinitis) outcome was unknown and MIGRAINE (extreme migraine), PAIN (aches and pains), PYREXIA (fever 100.2F), MYALGIA (body aches all over/slight soreness in the arm occasionally after the shot for a week or two) and HEADACHE (headache -25 Feb 2021) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 26-Feb-2021, Body temperature: 110.2 (High) fever 100.2F. On 27-Feb-2021, Body temperature: 97.7 (normal) temperature 99.7F.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Action taken with mRNA-1273 in response to the event was not applicable.  No concomitant medications were reported. Treatment medications included Tylenol and Bayer's Aspirin which was prescribed by the nurse and it did not resolve the condition. HCP prescribed Excedrin which resolved the events.   Most recent FOLLOW-UP information incorporated above includes: On 26-May-2021: events are updated
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Rhinitis allergic
Clinical narrative: allergic rhinitis; extreme migraine; fever 100.2F; body aches all over/slight soreness in the arm occasionally after the shot for a week or two; headache -25 Feb 2021; aches and pains; This case was initially received via an unknown source (no reference has been entered for a health authority or license partner) on 27-Feb-2021. The most recent information was received on 26-May-2021 and was forwarded to Moderna on 26-May-2021.    This spontaneous case was reported by a consumer and describes the occurrence of RHINITIS ALLERGIC (allergic rhinitis), MIGRAINE (extreme migraine), PAIN (aches and pains), PYREXIA (fever 100.2F) and MYALGIA (body aches all over/slight soreness in the arm occasionally after the shot for a week or two) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Previously administered products included for an unreported indication: SHINGRIX.   On 25-Feb-2021 at 1:00 PM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2021, the patient experienced PAIN (aches and pains) and HEADACHE (headache -25 Feb 2021). On 26-Feb-2021, the patient experienced MIGRAINE (extreme migraine), PYREXIA (fever 100.2F) and MYALGIA (body aches all over/slight soreness in the arm occasionally after the shot for a week or two). On an unknown date, the patient experienced RHINITIS ALLERGIC (allergic rhinitis). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at an unspecified dose and frequency; ACETYLSALICYLIC ACID (BAYER ASPIRIN) at an unspecified dose and frequency and ACETYLSALICYLIC ACID, CAFFEINE, PARACETAMOL (EXCEDRIN MIGRAINE) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, RHINITIS ALLERGIC (allergic rhinitis) outcome was unknown and MIGRAINE (extreme migraine), PAIN (aches and pains), PYREXIA (fever 100.2F), MYALGIA (body aches all over/slight soreness in the arm occasionally after the shot for a week or two) and HEADACHE (headache -25 Feb 2021) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 26-Feb-2021, Body temperature: 110.2 (High) fever 100.2F. On 27-Feb-2021, Body temperature: 97.7 (normal) temperature 99.7F.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Action taken with mRNA-1273 in response to the event was not applicable.  No concomitant medications were reported. Treatment medications included Tylenol and Bayer's Aspirin which was prescribed by the nurse and it did not resolve the condition. HCP prescribed Excedrin which resolved the events.   Most recent FOLLOW-UP information incorporated above includes: On 26-May-2021: events are updated
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chest pain, Chills, Headache, Myalgia
Clinical narrative: headache; Body ache; chills; chest pain; joint pain; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache), MYALGIA (Body ache), CHILLS (chills), CHEST PAIN (chest pain) and ARTHRALGIA (joint pain) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 20-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage form. On 21-Feb-2021, the patient experienced HEADACHE (headache), MYALGIA (Body ache), CHILLS (chills), CHEST PAIN (chest pain), ARTHRALGIA (joint pain) and NAUSEA (Nausea). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at an unspecified dose and frequency and NAPROXEN (MOTRIN [NAPROXEN]) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, HEADACHE (headache), MYALGIA (Body ache), CHILLS (chills), CHEST PAIN (chest pain), ARTHRALGIA (joint pain) and NAUSEA (Nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant Medications were not provided by the reporter.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea
Clinical narrative: headache; Body ache; chills; chest pain; joint pain; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache), MYALGIA (Body ache), CHILLS (chills), CHEST PAIN (chest pain) and ARTHRALGIA (joint pain) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 20-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage form. On 21-Feb-2021, the patient experienced HEADACHE (headache), MYALGIA (Body ache), CHILLS (chills), CHEST PAIN (chest pain), ARTHRALGIA (joint pain) and NAUSEA (Nausea). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at an unspecified dose and frequency and NAPROXEN (MOTRIN [NAPROXEN]) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, HEADACHE (headache), MYALGIA (Body ache), CHILLS (chills), CHEST PAIN (chest pain), ARTHRALGIA (joint pain) and NAUSEA (Nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant Medications were not provided by the reporter.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Myalgia, Pyrexia
Clinical narrative: tired; Body aches; Fever; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 26-Feb-2021 and was forwarded to the company on 26-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (tired), MYALGIA (Body aches) and PYREXIA (Fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In February 2021, the patient experienced FATIGUE (tired), MYALGIA (Body aches) and PYREXIA (Fever). At the time of the report, FATIGUE (tired), MYALGIA (Body aches) and PYREXIA (Fever) outcome was unknown.            No concomitant medication were reported No treatment medication were reported. The patient received both scheduled doses of mRNA-1273 prior to the event, therefore action taken with the drug in the event is not applicable
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site rash
Clinical narrative: arm is throbbing; rash is a circle with a red dot inside; bright red dot, elevated, 2in from injection site - small in size 1/4in; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (arm is throbbing), VACCINATION SITE RASH (rash is a circle with a red dot inside) and VACCINATION SITE ERYTHEMA (bright red dot, elevated, 2in from injection site - small in size 1/4in) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012120A and 010M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 25-Feb-2021, the patient experienced VACCINATION SITE PAIN (arm is throbbing), VACCINATION SITE RASH (rash is a circle with a red dot inside) and VACCINATION SITE ERYTHEMA (bright red dot, elevated, 2in from injection site - small in size 1/4in). At the time of the report, VACCINATION SITE PAIN (arm is throbbing), VACCINATION SITE RASH (rash is a circle with a red dot inside) and VACCINATION SITE ERYTHEMA (bright red dot, elevated, 2in from injection site - small in size 1/4in) outcome was unknown.            No concomitant medication details was reported. No treatment medication details was reported. Action taken with mRNA-1273 in response to the events was not applicable.
Sex: U
Vaccine: COVID19
Symptoms: Product administration error
Clinical narrative: mixed doses from multiple vials to obtain a full dose and gave it to 2 patients; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 26-Feb-2021 and was forwarded to Moderna on 26-Feb-2021.    This spontaneous case was reported by a physician and describes the occurrence of PRODUCT ADMINISTRATION ERROR (mixed doses from multiple vials to obtain a full dose and gave it to 2 patients) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTRATION ERROR (mixed doses from multiple vials to obtain a full dose and gave it to 2 patients). At the time of the report, PRODUCT ADMINISTRATION ERROR (mixed doses from multiple vials to obtain a full dose and gave it to 2 patients) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication were reported No treatment medication were reported.    This case was linked to MOD-2021-028634 (Linked Report). This case was linked to MOD-2021-036880 (Patient Link).; Sender's Comments:  MOD-2021-028634:
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: soreness; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 26-Feb-2021 and was forwarded to Moderna on 26-Feb-2021.    This spontaneous case was reported by a non-health professional and describes the occurrence of PAIN (soreness) in an 80-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-Feb-2021, the patient experienced PAIN (soreness). At the time of the report, PAIN (soreness) outcome was unknown. Not Provided          No concomitant medication were reported No treatment medication were reported. The patient received both scheduled doses of mRNA-1273 prior to the event, therefore action taken with the drug in the event is not applicable
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site swelling, Myalgia, Vaccination site pruritus
Clinical narrative: soreness at injection site of the arm; swelling at injection site of the arm; Redness; Itching; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Itching), MYALGIA (soreness at injection site of the arm), INJECTION SITE SWELLING (swelling at injection site of the arm) and INJECTION SITE ERYTHEMA (Redness) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (Itching), MYALGIA (soreness at injection site of the arm), INJECTION SITE SWELLING (swelling at injection site of the arm) and INJECTION SITE ERYTHEMA (Redness). At the time of the report, VACCINATION SITE PRURITUS (Itching), MYALGIA (soreness at injection site of the arm), INJECTION SITE SWELLING (swelling at injection site of the arm) and INJECTION SITE ERYTHEMA (Redness) had not resolved.            Treatment details included Benadryl Cream, Ice pack. Action taken with mRNA-1273 in response to the events was not reported.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia
Clinical narrative: Elbow pain; Joint Pain; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (Elbow pain) and ARTHRALGIA (Joint Pain) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Feb-2021, the patient experienced ARTHRALGIA (Elbow pain) and ARTHRALGIA (Joint Pain). At the time of the report, ARTHRALGIA (Elbow pain) and ARTHRALGIA (Joint Pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication details was reported. No treatment medication details was reported.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Malaise, Nausea, Pyrexia
Clinical narrative: was feeling sick; temperature start to go up 101.7F; nauseous; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 26-Feb-2021 and was forwarded to Moderna on 28-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (was feeling sick), PYREXIA (temperature start to go up 101.7F) and NAUSEA (nauseous) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced MALAISE (was feeling sick), PYREXIA (temperature start to go up 101.7F) and NAUSEA (nauseous). At the time of the report, MALAISE (was feeling sick), PYREXIA (temperature start to go up 101.7F) and NAUSEA (nauseous) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication were reported No treatment medication were reported. Patient got temperature 101.7F
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Underdose
Clinical narrative: Half of the vaccine spilled on her arm; A spontaneous report was received from a Consumer concerning a 51-years-old female patient who received Moderna's COVID-19 vaccine and half of the vaccine spilled on her arm (vaccine under dose).  The patient's medical history was not included. Concomitant medications included aliskiren fumarate and amlodipine.  On 27 Feb 2021, prior to onset of the events, the patient received their dose of mRNA-1273 (Batch number: 031L20A) intramuscularly in the arm for prophylaxis of COVID-19 infection.   On 27 Feb 2021, the patient noticed that half of the vaccine spilled on her arm (vaccine under dose). No treatment information was provided.  Action taken with mRNA-1273 in response to the event was not provided.   The outcome of the event vaccine spilled on her arm (vaccine under dose) was considered recovered.; Reporter's Comments: This report refers to a case of under-dose for mRNA-1273.  There were no reported adverse events associated with this case.
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Feeling hot, Pruritus, Skin reaction, Swelling
Clinical narrative: delayed response to the first shot of the vaccine; quite itchy; red; swollen; warm; it's not as swollen but the redness has extended to her elbow; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 27-Feb-2021 and was forwarded to Moderna on 28-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of SKIN REACTION (delayed response to the first shot of the vaccine), PRURITUS (quite itchy), ERYTHEMA (red), SWELLING (swollen) and FEELING HOT (warm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SKIN REACTION (delayed response to the first shot of the vaccine), PRURITUS (quite itchy), ERYTHEMA (red), SWELLING (swollen), FEELING HOT (warm) and ERYTHEMA (it's not as swollen but the redness has extended to her elbow). At the time of the report, SKIN REACTION (delayed response to the first shot of the vaccine), PRURITUS (quite itchy), ERYTHEMA (red), SWELLING (swollen), FEELING HOT (warm) and ERYTHEMA (it's not as swollen but the redness has extended to her elbow) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Reporter did not allow further contact
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache, Vaccination site bruising, Vaccination site discolouration, Vaccination site pain
Clinical narrative: has a bruise that is black and blue; has a bruise that is black and blue; LITTLE BIT OF SORENESS, where shot the shot was; HEADACHE; TIREDNESS; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE DISCOLOURATION (has a bruise that is black and blue), VACCINATION SITE BRUISING (has a bruise that is black and blue), VACCINATION SITE PAIN (LITTLE BIT OF SORENESS, where shot the shot was), HEADACHE (HEADACHE) and FATIGUE (TIREDNESS) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, the patient experienced VACCINATION SITE DISCOLOURATION (has a bruise that is black and blue), VACCINATION SITE BRUISING (has a bruise that is black and blue), VACCINATION SITE PAIN (LITTLE BIT OF SORENESS, where shot the shot was), HEADACHE (HEADACHE) and FATIGUE (TIREDNESS). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, VACCINATION SITE DISCOLOURATION (has a bruise that is black and blue), VACCINATION SITE BRUISING (has a bruise that is black and blue), VACCINATION SITE PAIN (LITTLE BIT OF SORENESS, where shot the shot was), HEADACHE (HEADACHE) and FATIGUE (TIREDNESS) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product information was not provided by the reporter.
Age: 89.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pain, Vaccination site warmth
Clinical narrative: warm to touch; red; a little pain; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (warm to touch), PAIN (a little pain) and ERYTHEMA (red) in an 89-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M20A) for COVID-19 vaccination.     The patient's past medical history included Stent placement. Concurrent medical conditions included Diabetes.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Feb-2021, the patient experienced PAIN (a little pain). On 24-Feb-2021, the patient experienced VACCINATION SITE WARMTH (warm to touch) and ERYTHEMA (red). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE WARMTH (warm to touch), PAIN (a little pain) and ERYTHEMA (red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 29-Apr-2021: NNI
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chest pain, Dyspnoea, Gait disturbance, Pyrexia
Clinical narrative: Labored breathing; Chest pains; Could barely stand up; Rash from her leg to buttocks area; Fever of 102 degrees; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Labored breathing), CHEST PAIN (Chest pains), GAIT DISTURBANCE (Could barely stand up), RASH (Rash from her leg to buttocks area) and PYREXIA (Fever of 102 degrees) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 24-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Feb-2021, the patient experienced DYSPNOEA (Labored breathing), CHEST PAIN (Chest pains), GAIT DISTURBANCE (Could barely stand up), RASH (Rash from her leg to buttocks area) and PYREXIA (Fever of 102 degrees). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, DYSPNOEA (Labored breathing), CHEST PAIN (Chest pains), GAIT DISTURBANCE (Could barely stand up), RASH (Rash from her leg to buttocks area) and PYREXIA (Fever of 102 degrees) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 102 (High) high.         As reported patient experienced a rash from her leg to buttocks area, fever of 102 degrees, labored breathing, chest pains, and could barely stand up. Patient used rescue inhaler to alleviate the adverse event.  Concomitant medications were not reported.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Labored breathing; Chest pains; Could barely stand up; Rash from her leg to buttocks area; Fever of 102 degrees; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Labored breathing), CHEST PAIN (Chest pains), GAIT DISTURBANCE (Could barely stand up), RASH (Rash from her leg to buttocks area) and PYREXIA (Fever of 102 degrees) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 24-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Feb-2021, the patient experienced DYSPNOEA (Labored breathing), CHEST PAIN (Chest pains), GAIT DISTURBANCE (Could barely stand up), RASH (Rash from her leg to buttocks area) and PYREXIA (Fever of 102 degrees). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, DYSPNOEA (Labored breathing), CHEST PAIN (Chest pains), GAIT DISTURBANCE (Could barely stand up), RASH (Rash from her leg to buttocks area) and PYREXIA (Fever of 102 degrees) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 102 (High) high.         As reported patient experienced a rash from her leg to buttocks area, fever of 102 degrees, labored breathing, chest pains, and could barely stand up. Patient used rescue inhaler to alleviate the adverse event.  Concomitant medications were not reported.
Sex: F
Vaccine: COVID19
Symptoms: Drug ineffective
Clinical narrative: Tested negative for antibodies one month after the second dose; A spontaneous report was received from a pharmacist concerning a female patient of an unknown age who received Moderna's COVID-19 vaccine (mRNA-1273) and tested negative for antibodies one month after the second dose.  The patient's medical history was not provided. No concomitant medications were provided.  The patient received their first of two planned doses of mRNA-1273 (Batch number: 037K20A) on 26 Dec 2020. On 22 Jan 2021, the patient received their second of two planned doses of mRNA-1273 (Batch number: 043L20A) intramuscularly in the left arm for prophylaxis of COVID-19 infection.  The patient received both doses of vaccine and one month after the second dose blood test was performed and tested negative for antibodies (lack of drug effect).  The patient received both scheduled doses of mRNA-1273 prior to the events, therefore action taken with the drug in response to the events was not applicable.  The outcome of the event tested negative for antibodies one month after the second dose was not provided.; Reporter's Comments: This refers to a case of a female patient who received both mRNA-1273 doses within a month (lot #s 037K20A, 043L20A) and experienced drug ineffective with no associated AEs.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Body temperature, Chills, Fatigue, Headache
Clinical narrative: fever with T-max of 101.7; fatigue; Arthralgias; headache; chills; This spontaneous case was reported by a health care professional (subsequently medically confirmed) and describes the occurrence of PYREXIA (fever with T-max of 101.7), FATIGUE (fatigue), ARTHRALGIA (Arthralgias), HEADACHE (headache) and CHILLS (chills) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032L206 and 026L206) for COVID-19 vaccination.     No Medical History information was reported.   On 28-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021 at 10:00 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 26-Jan-2021, the patient experienced PYREXIA (fever with T-max of 101.7), FATIGUE (fatigue), ARTHRALGIA (Arthralgias), HEADACHE (headache) and CHILLS (chills). On 27-Jan-2021, PYREXIA (fever with T-max of 101.7), FATIGUE (fatigue), ARTHRALGIA (Arthralgias), HEADACHE (headache) and CHILLS (chills) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 26-Jan-2021, Body temperature: 101.7 f High.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered PYREXIA (fever with T-max of 101.7), FATIGUE (fatigue), ARTHRALGIA (Arthralgias), HEADACHE (headache) and CHILLS (chills) to be probably related.    The  concomitant medications were not provided. Treatment medications included Acetaminophene.   Most recent FOLLOW-UP information incorporated above includes: On 10-Jun-2021: Follow up received on 10-JUN-2021 and Date of vaccination, AE details and outcome were updated.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: fever with T-max of 101.7; fatigue; Arthralgias; headache; chills; This spontaneous case was reported by a health care professional (subsequently medically confirmed) and describes the occurrence of PYREXIA (fever with T-max of 101.7), FATIGUE (fatigue), ARTHRALGIA (Arthralgias), HEADACHE (headache) and CHILLS (chills) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032L206 and 026L206) for COVID-19 vaccination.     No Medical History information was reported.   On 28-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021 at 10:00 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 26-Jan-2021, the patient experienced PYREXIA (fever with T-max of 101.7), FATIGUE (fatigue), ARTHRALGIA (Arthralgias), HEADACHE (headache) and CHILLS (chills). On 27-Jan-2021, PYREXIA (fever with T-max of 101.7), FATIGUE (fatigue), ARTHRALGIA (Arthralgias), HEADACHE (headache) and CHILLS (chills) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 26-Jan-2021, Body temperature: 101.7 f High.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered PYREXIA (fever with T-max of 101.7), FATIGUE (fatigue), ARTHRALGIA (Arthralgias), HEADACHE (headache) and CHILLS (chills) to be probably related.    The  concomitant medications were not provided. Treatment medications included Acetaminophene.   Most recent FOLLOW-UP information incorporated above includes: On 10-Jun-2021: Follow up received on 10-JUN-2021 and Date of vaccination, AE details and outcome were updated.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Feeling of relaxation, Headache, Illness, Pyrexia
Clinical narrative: feeling okay 26 Feb 2021; very sick 24 Feb 2021; chills 24 Feb 2021; headaches 24 Feb 2021; fever 102.2F 24 Feb 2021; fever 99.1F at 11am 25 Feb 2021; fever 101F at 4pm 25 Feb 2021; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 27-Feb-2021 and was forwarded to Moderna on 27-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of FEELING OF RELAXATION (feeling okay 26 Feb 2021), ILLNESS (very sick 24 Feb 2021), CHILLS (chills 24 Feb 2021), HEADACHE (headaches 24 Feb 2021) and PYREXIA (fever 102.2F 24 Feb 2021) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced FEELING OF RELAXATION (feeling okay 26 Feb 2021), ILLNESS (very sick 24 Feb 2021), CHILLS (chills 24 Feb 2021), HEADACHE (headaches 24 Feb 2021), PYREXIA (fever 102.2F 24 Feb 2021), PYREXIA (fever 99.1F at 11am 25 Feb 2021) and PYREXIA (fever 101F at 4pm 25 Feb 2021). At the time of the report, FEELING OF RELAXATION (feeling okay 26 Feb 2021), ILLNESS (very sick 24 Feb 2021), CHILLS (chills 24 Feb 2021), HEADACHE (headaches 24 Feb 2021), PYREXIA (fever 102.2F 24 Feb 2021), PYREXIA (fever 99.1F at 11am 25 Feb 2021) and PYREXIA (fever 101F at 4pm 25 Feb 2021) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia
Clinical narrative: bad knees; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (bad knees) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ARTHRALGIA (bad knees). At the time of the report, ARTHRALGIA (bad knees) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication information was provided. No treatment medication information was provided.   Reporter did not allow further contact
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Myalgia, Pain in extremity
Clinical narrative: hands were hurting; feeling fatigue; Joint pains; Muscles aching; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 27-Feb-2021 and was forwarded to Moderna on 27-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (hands were hurting), FATIGUE (feeling fatigue), ARTHRALGIA (Joint pains) and MYALGIA (Muscles aching) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 042L20A and 030M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 26-Feb-2021, the patient experienced FATIGUE (feeling fatigue), ARTHRALGIA (Joint pains) and MYALGIA (Muscles aching). On an unknown date, the patient experienced PAIN IN EXTREMITY (hands were hurting). At the time of the report, PAIN IN EXTREMITY (hands were hurting), FATIGUE (feeling fatigue), ARTHRALGIA (Joint pains) and MYALGIA (Muscles aching) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 29-Apr-2021: No specific follow-up information recorded.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Myalgia, Nausea, Pyrexia, Vomiting
Clinical narrative: Body aches; nausea; vomiting; chills; fever; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Body aches), NAUSEA (nausea), VOMITING (vomiting), CHILLS (chills) and PYREXIA (fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Feb-2021 at 7:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, the patient experienced MYALGIA (Body aches), NAUSEA (nausea), VOMITING (vomiting), CHILLS (chills) and PYREXIA (fever). At the time of the report, MYALGIA (Body aches), NAUSEA (nausea), VOMITING (vomiting), CHILLS (chills) and PYREXIA (fever) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. Treatment medications not specified.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain, Vaccination site swelling
Clinical narrative: little sore at injection site; swollen at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (little sore at injection site) and VACCINATION SITE SWELLING (swollen at injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 27-Jan-2021, the patient experienced VACCINATION SITE PAIN (little sore at injection site) and VACCINATION SITE SWELLING (swollen at injection site). At the time of the report, VACCINATION SITE PAIN (little sore at injection site) and VACCINATION SITE SWELLING (swollen at injection site) outcome was unknown.            Action taken with mRNA-1273 in response to the events was not Applicable.  Concomitant product use was not provided by the reporter. Treatment information was not provided.   This case was linked to MOD-2021-028543 (Patient Link).
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Axillary pain, Chills, Erythema, Fatigue
Clinical narrative: tenderness; slightly raised; itchy; fever; muscle and joint pain; muscle and joint pain; chills; big red splotchy area an inch below injection site; fatigue; sore by armpit; This spontaneous case was reported by a consumer and describes the occurrence of TENDERNESS (tenderness), RASH PAPULAR (slightly raised), VACCINATION SITE PRURITUS (itchy), ERYTHEMA (big red splotchy area an inch below injection site) and FATIGUE (fatigue) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Kidney cancer in 2017. Concomitant products included DOXYCYCLINE for an unknown indication.    On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, the patient experienced FATIGUE (fatigue). On 25-Feb-2021, the patient experienced TENDERNESS (tenderness), RASH PAPULAR (slightly raised), VACCINATION SITE PRURITUS (itchy), ERYTHEMA (big red splotchy area an inch below injection site), PYREXIA (fever), MYALGIA (muscle and joint pain), ARTHRALGIA (muscle and joint pain) and CHILLS (chills). At the time of the report, TENDERNESS (tenderness), RASH PAPULAR (slightly raised), VACCINATION SITE PRURITUS (itchy), ERYTHEMA (big red splotchy area an inch below injection site), FATIGUE (fatigue), PYREXIA (fever), MYALGIA (muscle and joint pain), ARTHRALGIA (muscle and joint pain) and CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Pyrexia, Rash papular, Tenderness, Vaccination site pruritus
Clinical narrative: tenderness; slightly raised; itchy; fever; muscle and joint pain; muscle and joint pain; chills; big red splotchy area an inch below injection site; fatigue; sore by armpit; This spontaneous case was reported by a consumer and describes the occurrence of TENDERNESS (tenderness), RASH PAPULAR (slightly raised), VACCINATION SITE PRURITUS (itchy), ERYTHEMA (big red splotchy area an inch below injection site) and FATIGUE (fatigue) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Kidney cancer in 2017. Concomitant products included DOXYCYCLINE for an unknown indication.    On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, the patient experienced FATIGUE (fatigue). On 25-Feb-2021, the patient experienced TENDERNESS (tenderness), RASH PAPULAR (slightly raised), VACCINATION SITE PRURITUS (itchy), ERYTHEMA (big red splotchy area an inch below injection site), PYREXIA (fever), MYALGIA (muscle and joint pain), ARTHRALGIA (muscle and joint pain) and CHILLS (chills). At the time of the report, TENDERNESS (tenderness), RASH PAPULAR (slightly raised), VACCINATION SITE PRURITUS (itchy), ERYTHEMA (big red splotchy area an inch below injection site), FATIGUE (fatigue), PYREXIA (fever), MYALGIA (muscle and joint pain), ARTHRALGIA (muscle and joint pain) and CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.